Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01624246 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
A Phase 1 study, sponsored by Forest Laboratories.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01624246 is a Phase 1 study that has completed, run by Forest Laboratories. The registered enrollment target is 12 participants.
The verdict
NCT01624246, a Phase 1 study, has completed, sponsored by Forest Laboratories.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
To evaluate the pharmacokinetic (PK) profiles of ceftaroline and avibactam in adults with augmented renal clearance (ARC).
Interventions
- DRUG Ceftaroline fosamil/Avibactam (CXL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01624246
The ClinicalTrials.gov registry entry for NCT01624246 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ceftaroline fosamil/Avibactam (CXL) is the first listed.
NCT01624246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01624246 about?
NCT01624246 is a clinical study titled "Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance". To evaluate the pharmacokinetic (PK) profiles of ceftaroline and avibactam in adults with augmented renal clearance (ARC).
What is the current status of trial NCT01624246?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2012-05. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01624246?
The interventions under investigation include: Ceftaroline fosamil/Avibactam (CXL) (DRUG).
Who is sponsoring clinical trial NCT01624246?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.